Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


1 Am J Surg
2 Ann Oncol
1 Ann Surg
3 Anticancer Res
1 BMC Cancer
4 Br J Cancer
1 Cancer
2 Cancer Lett
1 Cancer Res
7 Dis Colon Rectum
5 Eur J Cancer
4 Eur J Surg Oncol
3 Gastroenterology
2 Gut
2 Int J Cancer
1 Int J Colorectal Dis
1 J Am Coll Surg
1 J Clin Oncol
1 J Nucl Med
3 J Surg Oncol
1 Lancet Oncol
1 Oncogene
11 PLoS One

    Am J Surg

  1. MBAH N, Agle SC, Philips P, Egger ME, et al
    Laparoscopic hepatectomy significantly shortens the time to postoperative chemotherapy in patients undergoing major hepatectomies.
    Am J Surg. 2017;213:1060-1064.
    >> Share

    Ann Oncol

  2. WHITE NM, Maher CA
    The potential use of lncRNAs found in the 8q24 region as biomarkers for colon cancer.
    Ann Oncol. 2017;28:1688-1689.
    >> Share

  3. OZAWA T, Matsuyama T, Toiyama Y, Takahashi N, et al
    CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
    Ann Oncol. 2017;28:1882-1888.
    >> Share

    Ann Surg

  4. FUJITA S, Mizusawa J, Kanemitsu Y, Ito M, et al
    Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Ann Surg. 2017;266:201-207.
    >> Share

    Anticancer Res

  5. PINSK V, Pinsk I, Ling G, Yerushalmi B, et al
    Complete Reversion of Familial Adenomatous Polyposis Phenotype Associated with Tacrolimus and Mycophenolate Mofetil Treatment Following Kidney Transplantation.
    Anticancer Res. 2017;37:3105-3109.
    >> Share

  6. KINUGASA T, Mizobe T, Shiraiwa S, Akagi Y, et al
    Perineural Invasion Is a Prognostic Factor and Treatment Indicator in Patients with Rectal Cancer Undergoing Curative Surgery: 2000-2011 Data from a Single-center Study.
    Anticancer Res. 2017;37:3961-3968.
    >> Share

  7. BADAKHSHI H, Ismail M, Boskos C, Zhao K, et al
    The Role of Concomitant Radiation Boost in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2017;37:3201-3205.
    >> Share

    BMC Cancer

  8. AYKUT B, Ochs M, Radhakrishnan P, Brill A, et al
    EMX2 gene expression predicts liver metastasis and survival in colorectal cancer.
    BMC Cancer. 2017;17:555.
    >> Share

    Br J Cancer

  9. GASH KJ, Chambers AC, Cotton DE, Williams AC, et al
    Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.
    Br J Cancer. 2017;117:210-219.
    >> Share

  10. BENTON SC, Butler P, Allen K, Chesters M, et al
    GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
    Br J Cancer. 2017;116:1551-1557.
    >> Share

  11. SIDDIQUI MRS, Simillis C, Hunter C, Chand M, et al
    A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.
    Br J Cancer. 2017;116:1513-1519.
    >> Share

  12. FREISLING H, Arnold M, Soerjomataram I, O'Doherty MG, et al
    Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe.
    Br J Cancer. 2017;116:1486-1497.
    >> Share


  13. KOCARNIK JM, Hua X, Hardikar S, Robinson J, et al
    Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30932.
    >> Share

    Cancer Lett

  14. OBERTHUR R, Seemann H, Gehrig J, Rave-Frank M, et al
    Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death.
    Cancer Lett. 2017 Aug 18. pii: S0304-3835(17)30486.
    >> Share

  15. TAGHAVI S, Ramezani M, Alibolandi M, Abnous K, et al
    Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Cancer Lett. 2017;400:1-8.
    >> Share

    Cancer Res

  16. JIN L, Vu T, Yuan G, Datta PK, et al
    STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathway.
    Cancer Res. 2017 Aug 21. pii: canres.0286.2017.
    >> Share

    Dis Colon Rectum

  17. BROWN KGM, Solomon MJ, Koh CE
    Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy.
    Dis Colon Rectum. 2017;60:745-754.
    >> Share

  18. GARFINKLE R, Abou-Khalil J, Morin N, Ghitulescu G, et al
    Is There a Role for Oral Antibiotic Preparation Alone Before Colorectal Surgery? ACS-NSQIP Analysis by Coarsened Exact Matching.
    Dis Colon Rectum. 2017;60:729-737.
    >> Share

  19. FROUWS MA, Snijders HS, Malm SH, Liefers GJ, et al
    Clinical Relevance of a Grading System for Anastomotic Leakage After Low Anterior Resection: Analysis From a National Cohort Database.
    Dis Colon Rectum. 2017;60:706-713.
    >> Share

  20. QIN Q, Huang B, Cao W, Zhou J, et al
    Bowel Dysfunction After Low Anterior Resection With Neoadjuvant Chemoradiotherapy or Chemotherapy Alone for Rectal Cancer: A Cross-Sectional Study from China.
    Dis Colon Rectum. 2017;60:697-705.
    >> Share

  21. MEHTA AM, Bignell MB, Alves S, Dayal SP, et al
    Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.
    Dis Colon Rectum. 2017;60:691-696.
    >> Share

  22. KWAAN MR, Fan Y, Jarosek S, Elliott SP, et al
    Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis.
    Dis Colon Rectum. 2017;60:682-690.
    >> Share

  23. ROUANET P, Rullier E, Lelong B, Maingon P, et al
    Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial.
    Dis Colon Rectum. 2017;60:653-663.
    >> Share

    Eur J Cancer

  24. ADAM R, Yi B, Innominato PF, Barroso E, et al
    Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients.
    Eur J Cancer. 2017;78:7-15.
    >> Share

  25. YOSHINO T, Obermannova R, Bodoky G, Garcia-Carbonero R, et al
    Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial.
    Eur J Cancer. 2017;78:61-69.
    >> Share

  26. D'AMBROSIO L, Palesandro E, Boccone P, Tolomeo F, et al
    Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour.
    Eur J Cancer. 2017;78:122-132.
    >> Share

  27. STINTZING S, Miller-Phillips L, Modest DP, Fischer von Weikersthal L, et al
    Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.
    Eur J Cancer. 2017;79:50-60.
    >> Share

  28. MAY-WILSON S, Sud A, Law PJ, Palin K, et al
    Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.
    Eur J Cancer. 2017;84:228-238.
    >> Share

    Eur J Surg Oncol

  29. BAUKLOH JK, Reeh M, Spinoglio G, Corratti A, et al
    Evaluation of the robotic approach concerning pitfalls in rectal surgery.
    Eur J Surg Oncol. 2017;43:1304-1311.
    >> Share

  30. DELHORME JB, Sattler L, Severac F, Triki E, et al
    Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?
    Eur J Surg Oncol. 2017;43:1095-1101.
    >> Share

  31. DE FELICE F, Magnante AL, Musio D, Ciolina M, et al
    Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Eur J Surg Oncol. 2017;43:1324-1329.
    >> Share

  32. HUBNER M, Grass F, Teixeira-Farinha H, Pache B, et al
    Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
    Eur J Surg Oncol. 2017;43:1102-1109.
    >> Share


  33. WONG SH, Zhao L, Zhang X, Nakatsu G, et al
    Gavage of Fecal Samples From Patients with Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-free and Conventional Mice.
    Gastroenterology. 2017 Aug 17. pii: S0016-5085(17)36038.
    >> Share

  34. LIEBERMAN S, Walsh T, Schechter M, Adar T, et al
    Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.
    Gastroenterology. 2017;152:1876-1880.
    >> Share

  35. ANDERSON JC, Baron JA, Ahnen DJ, Barry EL, et al
    Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
    Gastroenterology. 2017;152:1933-1943.
    >> Share


  36. DIGBY J, Fraser CG, Carey FA, Steele RJC, et al
    Can the performance of a quantitative FIT-based colorectal cancer screening programme be enhanced by lowering the threshold and increasing the interval?
    Gut. 2017 Aug 24. pii: gutjnl-2017-314862. doi: 10.1136/gutjnl-2017-314862.
    >> Share

  37. EAST JE, Atkin WS, Bateman AC, Clark SK, et al
    British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.
    Gut. 2017;66:1181-1196.
    >> Share

    Int J Cancer

  38. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    >> Share

  39. EKLOF V, Lofgren-Burstrom A, Zingmark C, Edin S, et al
    Cancer associated faecal microbial markers in colorectal cancer detection.
    Int J Cancer. 2017 Aug 22. doi: 10.1002/ijc.31011.
    >> Share

    Int J Colorectal Dis

  40. PATEL A, Williams N, Parsons N, Ali O, et al
    Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.
    Int J Colorectal Dis. 2017 Aug 21. doi: 10.1007/s00384-017-2881.
    >> Share

    J Am Coll Surg

  41. GAHAGAN JV, Whealon MD, Phelan MJ, Mills S, et al
    Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter?
    J Am Coll Surg. 2017;225:69-75.
    >> Share

    J Clin Oncol

  42. KASTRINOS F, Uno H, Ukaegbu C, Alvero C, et al
    Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.
    J Clin Oncol. 2017;35:2165-2172.
    >> Share

    J Nucl Med

  43. SCHULZ J, Rohracker M, Stiebler M, Goldschmidt J, et al
    Proof of Therapeutic Efficacy of a 177Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model.
    J Nucl Med. 2017;58:936-941.
    >> Share

    J Surg Oncol

  44. SUAREZ J, Marin G, Vera R, Colibaseanu D, et al
    Stent placement prior to initiation of chemotherapy in patients with obstructive, nonoperative left sided tumors is associated with fewer stomas.
    J Surg Oncol. 2017;115:856-863.
    >> Share

  45. ABDELFATAH E, Page A, Sacks J, Pierorazio P, et al
    Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients.
    J Surg Oncol. 2017;115:883-890.
    >> Share

  46. TAKAHASHI H, Akyuz M, Aksoy E, Karabulut K, et al
    Local recurrence after laparoscopic radiofrequency ablation of malignant liver tumors: Results of a contemporary series.
    J Surg Oncol. 2017;115:830-834.
    >> Share

    Lancet Oncol

  47. CARVALHO C, Glynne-Jones R
    Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer.
    Lancet Oncol. 2017;18:e354-e363.
    >> Share


  48. LI XX, Zhang HS, Xu YM, Zhang RJ, et al
    Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    >> Share

    PLoS One

  49. KIM KH, Yeo SG, Yoo BC, Myung JK, et al
    Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells.
    PLoS One. 2017;12:e0171232.
    >> Share

  50. FASTERIUS E, Raso C, Kennedy S, Rauch N, et al
    A novel RNA sequencing data analysis method for cell line authentication.
    PLoS One. 2017;12:e0171435.
    >> Share

  51. LIEDER B, Hoi JK, Holik AK, Geissler K, et al
    The flavanone homoeriodictyol increases SGLT-1-mediated glucose uptake but decreases serotonin release in differentiated Caco-2 cells.
    PLoS One. 2017;12:e0171580.
    >> Share

  52. ARSIC N, Ho-Pun-Cheung A, Evelyne C, Assenat E, et al
    The p53 isoform delta133p53ss regulates cancer cell apoptosis in a RhoB-dependent manner.
    PLoS One. 2017;12:e0172125.
    >> Share

  53. LEWITOWICZ P, Gluszek S, Koziel D, Horecka-Lewitowicz A, et al
    Conventional colon adenomas harbor various disturbances in microsatellite stability and contain micro-serrated foci with microsatellite instability.
    PLoS One. 2017;12:e0172381.
    >> Share

  54. ZHAO J, Salomon MP, Shibata D, Curtis C, et al
    Early mutation bursts in colorectal tumors.
    PLoS One. 2017;12:e0172516.
    >> Share

  55. OTTERPOHL KL, Gould KA
    Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk.
    PLoS One. 2017;12:e0172247.
    >> Share

  56. KASHIWAGI K, Inoue N, Yoshida T, Bessyo R, et al
    Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy.
    PLoS One. 2017;12:e0174155.
    >> Share

  57. PELLINO G, Simillis C, Qiu S, Rasheed S, et al
    Social media and colorectal cancer: A systematic review of available resources.
    PLoS One. 2017;12:e0183031.
    >> Share

  58. ALMASUD AA, Giles KH, Miklavcic JJ, Martins KJB, et al
    Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer.
    PLoS One. 2017;12:e0183576.
    >> Share

  59. PURCELL RV, Pearson J, Aitchison A, Dixon L, et al
    Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia.
    PLoS One. 2017;12:e0171602.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016